Therapeutic effects of Tmprss6 suppression are negated by iron overload in a mouse model of beta-thalassemia
Authors
Discussion
Loading...
Member takes
Implication
Inhibition of Tmprss6 improves anemia and erythropoiesis in beta-thalassemia, suggesting that high iron levels may reduce its effectiveness.
Key Points
- This study aims to assess how iron overload affects the therapeutic impact of Tmprss6 suppression in beta-thalassemia.
- Utilized Tmprss6 ASO and non-targeting ASO in various mouse models including T-E, Th3, and wildtype controls.
- Administered weekly intraperitoneal injections of ASO for four weeks and assessed liver Tmprss6 and Hamp levels.
- Evaluated the impact of high iron conditions via iron dextran treatment and high iron diet.
- Tmprss6 suppression effectively increased hepcidin levels and reduced serum iron in normal conditions.
- The treatment was less effective in T-E mice with severe iron overload compared to Th3 mice.
- High iron conditions blunted the effects of Tmprss6 inhibition on iron metrics and erythropoiesis.
Cite This Study
Barrett et al. (2025) studied this question.